About us

The identification of promising new hits and their optimization into high-quality lead series is an essential step in the early stages of the modern drug discovery process. We established the Molecules Initiative for Neglected Diseases Consortium (MINDI) to discover novel drug candidates for clinical development for malaria, Chagas disease and leishmaniasis.

Learn more

Diseases

Home 

Chagas disease 

Home  Learn more
Home 

Visceral Leishmaniasis 

Home  Learn more
Home 

Malaria 

Home  Learn more

Research

The approach of MINDI Consortium is to use hits from both MMV and DNDi screening campaigns as starting points for lead optimization projects.

Learn more

Articles and papers

teste

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents 

Learn more
teste

An in vitro toolbox to accelerate anti-malarial drug discovery and development 

Learn more
teste

Structure-activity relationship of 4-azaindole-2-piperidine derivatives as agents against Trypanosoma cruzi 

Learn more
Home 

Events

Relevant events in Medicinal Chemistry and Drug Discovery.

Access Calendar

Partners

Mindi - Molecules Iniciative for Negleted Diseases

Unicamp
Rua Josué de Castro, s/n
Cidade Universitária Campinas
CEP: 13083-970 – SP